Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations
暂无分享,去创建一个
M. Taskinen | M. Orešič | K. Ekroos | L. Yetukuri | A. Kotronen | V. Velagapudi | J. Westerbacka | R. Bergholm | J. Makkonen | H. Yki-Järvinen | H. Yki-Järvinen | M.-R. Taskinen | A. Kotronen | V. R. Velagapudi | L. Yetukuri | J. Westerbacka | R. Bergholm | K. Ekroos | J. Makkonen | M. Orešič | M. Taskinen | Hannele Yki-Järvinen | Janne Makkonen | Matej Oresic | Kim Ekroos
[1] R. Wolfe,et al. Hepatic secretion of VLDL fatty acids during stimulated lipogenesis in men. , 1998, Journal of lipid research.
[2] Matej Oresic,et al. Lipidomics: a new window to biomedical frontiers. , 2008, Trends in biotechnology.
[3] A. Folsom,et al. Plasma fatty acid composition and incidence of coronary heart disease in middle aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. , 2003, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[4] G. Lewis,et al. Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity. , 2003, Clinical biochemistry.
[5] M. Katan,et al. Fatty acid composition of serum cholesteryl esters and erythrocyte membranes as indicators of linoleic acid intake in man. , 1989, The American journal of clinical nutrition.
[6] R. Zoeller,et al. Increasing plasmalogen levels protects human endothelial cells during hypoxia. , 2002, American journal of physiology. Heart and circulatory physiology.
[7] E. Parks,et al. Temporal pattern of de novo lipogenesis in the postprandial state in healthy men. , 2005, The American journal of clinical nutrition.
[8] D. Vance,et al. Sphingolipid Biosynthesis de Novo by Rat Hepatocytes in Culture. , 1995, The Journal of Biological Chemistry.
[9] J. Rood,et al. Relationship of dietary fat and serum cholesterol ester and phospholipid fatty acids to markers of insulin resistance in men and women with a range of glucose tolerance. , 2001, Metabolism: clinical and experimental.
[10] A. Hamsten,et al. Fatty acid handling protein expression in adipose tissue, fatty acid composition of adipose tissue and serum, and markers of insulin resistance , 2006, European Journal of Clinical Nutrition.
[11] J. Jessurun,et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.
[12] M. Taskinen,et al. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM , 1997, Diabetologia.
[13] B. S. Mohammed,et al. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. , 2008, Gastroenterology.
[14] J. Zeuthen,et al. Two-site time-resolved immunofluorometric assay of human insulin. , 1986, Clinical chemistry.
[15] Matej Oresic,et al. MZmine: toolbox for processing and visualization of mass spectrometry based molecular profile data , 2006, Bioinform..
[16] M. Ohrvall,et al. The serum cholesterol ester fatty acid composition but not the serum concentration of alpha tocopherol predicts the development of myocardial infarction in 50-year-old men: 19 years follow-up. , 1996, Atherosclerosis.
[17] T. Nikkari,et al. Fatty acid composition of serum lipid fractions in relation to gender and quality of dietary fat. , 1995, Annals of medicine.
[18] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[19] K. Pietiläinen,et al. Liver fat in the metabolic syndrome. , 2007, The Journal of clinical endocrinology and metabolism.
[20] M. Taskinen,et al. Metabolic basis of hypotriglyceridemic effects of insulin in normal men. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[21] E. Feskens,et al. Improvements in glucose tolerance and insulin sensitivity after lifestyle intervention are related to changes in serum fatty acid profile and desaturase activities: the SLIM study , 2006, Diabetologia.
[22] J. Huttunen,et al. Fatty-acid composition of serum lipids predicts myocardial infarction. , 1982, British medical journal.
[23] R. Havel,et al. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.
[24] L. Berglund,et al. The Risk to Develop NIDDM Is Related to the Fatty Acid Composition of the Serum Cholesterol Esters , 1994, Diabetes.
[25] Yii-Der I. Chen,et al. Measurement of Plasma Glucose, Free Fatty Acid, Lactate, and Insulin for 24 h in Patients With NIDDM , 1988, Diabetes.
[26] B. Vessby,et al. Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men , 2005, Diabetologia.
[27] I. Laakso,et al. Analysis of fatty acids by gas chromatography, and its relevance to research on health and nutrition , 2002 .
[28] D. English,et al. Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. , 2007, The American journal of clinical nutrition.
[29] B. M. Rasmussen,et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU study , 2001, Diabetologia.
[30] Paul Zimmet,et al. The metabolic syndrome—a new worldwide definition , 2005, The Lancet.
[31] J H Eckfeldt,et al. Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. , 1995, The American journal of clinical nutrition.
[32] J. Pankow,et al. Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. , 2003, The American journal of clinical nutrition.
[33] S. Summers,et al. Ceramides in insulin resistance and lipotoxicity. , 2006, Progress in lipid research.
[34] A. Häkkinen,et al. Overproduction of large VLDL particles is driven by increased liver fat content in man , 2006, Diabetologia.
[35] J. Després,et al. Associations between the fatty acid content of triglyceride, visceral adipose tissue accumulation, and components of the insulin resistance syndrome. , 2004, Metabolism: clinical and experimental.
[36] J. E.,et al. Serum phospholipid fatty acid composition and insulin action in type 2 diabetic patients , 2001 .
[37] A. Hamsten,et al. Measures of Oxidized Low-Density Lipoprotein and Oxidative Stress Are Not Related and Not Elevated in Otherwise Healthy Men With the Metabolic Syndrome , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[38] M. Kashyap,et al. A rapid and simple method for measurement of total protein in very low density lipoproteins by the Lowry assay. , 1980, Journal of lipid research.
[39] M. Taskinen. Type 2 diabetes as a lipid disorder. , 2005, Current molecular medicine.
[40] H. Lithell,et al. Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men , 1994, Diabetologia.
[41] M. Taskinen,et al. Insulin Therapy Induces Antiatherogenic Changes of Serum Lipoproteins in Noninsulin‐Dependent Diabetes , 1988, Arteriosclerosis.
[42] A. Häkkinen,et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. , 2002, The Journal of clinical endocrinology and metabolism.
[43] A. Kotronen,et al. Fatty Liver: A Novel Component of the Metabolic Syndrome , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[44] J. Sundström,et al. Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population-based prospective study. , 2008, The American journal of clinical nutrition.
[45] R. Mensink,et al. Fatty acids in serum cholesteryl esters as quantitative biomarkers of dietary intake in humans. , 1997, American journal of epidemiology.
[46] D. Vance,et al. Biochemistry of Lipids, Lipoproteins and Membranes , 2002 .
[47] M. Walker,et al. Insulin resistance, insulin response, and obesity as indicators of metabolic risk. , 2007, The Journal of clinical endocrinology and metabolism.